FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment
Related Experiment Video
Updated: Jun 27, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Qiuping Ma1, Wei Fu, Pengfei Li
1Department of Pathology, University of South Florida, College of Medicine, Tampa, Florida 33612-4799, USA.
Abstract:
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.
Insights
FoxO1 protein inhibits androgen receptor (AR) activity, impacting prostate cancer cell growth. This study reveals how PTEN and FoxO1 cooperate to suppress AR signaling, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a tumor suppressor.
- FoxO (forkhead subclass O) proteins are transcription factors regulated by AKT.
- PTEN inhibits androgen receptor (AR) activity via AKT signaling.
Purpose of the Study:
- To investigate the role of FoxO1 in AR inhibition by PTEN.
- To elucidate the molecular mechanisms underlying PTEN-mediated AR repression involving FoxO1.
- To establish FoxO proteins as mediators of the antagonism between AR and PTEN in prostate cancer.
Main Methods:
- Ectopic expression of FoxO1.
- RNA interference (RNAi) for FoxO1 knockdown.
- Mutational analysis of FoxO1.
- Mammalian two-hybrid and glutathione-S-transferase (GST) pull-down assays.
Main Results:
- FoxO1 repressed AR transcriptional activity, androgen-induced cell proliferation, and prostate-specific antigen production.
- FoxO1 knockdown increased AR activity in PTEN-intact cells and relieved PTEN-mediated inhibition.
- FoxO1 fragment 150-655 was essential for AR inhibition.
- PTEN-FoxO1 interaction interfered with AR N/C-terminal interaction and p160 coactivator recruitment.
Conclusions:
- FoxO1 directly inhibits AR activity and mediates PTEN's suppressive effects on AR.
- The PTEN-FoxO1 axis represents a novel mechanism for regulating AR signaling in prostate cancer.
- FoxO proteins are key players in the antagonistic relationship between AR and PTEN, relevant to prostate cancer progression.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators

